Spheroid body myopathy

Spheroid body myopathy is an extremely rare inherited muscle disorder (myopathy) characterized by the presence of distinctive spheroid bodies within skeletal muscle fibers on muscle biopsy. These spheroid bodies are abnormal cytoplasmic inclusions composed of myofibrillar material, typically found within type 1 (slow-twitch) muscle fibers. The disease primarily affects the skeletal muscular system, leading to progressive muscle weakness and wasting. Clinically, spheroid body myopathy presents with slowly progressive proximal muscle weakness, predominantly affecting the limb-girdle muscles. Patients may experience difficulty with activities such as climbing stairs, rising from a seated position, and lifting objects overhead. Some patients also develop axial muscle weakness and mild respiratory involvement as the disease progresses. The age of onset is variable, with cases reported from childhood through adulthood. The condition has been associated with mutations in the MYOT gene (myotilin), which is involved in sarcomere organization and Z-disc structure, linking it to the broader category of myofibrillar myopathies. There is currently no curative treatment for spheroid body myopathy. Management is supportive and symptomatic, including physical therapy to maintain mobility and muscle function, respiratory monitoring, and orthopedic interventions as needed. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, knowledge is largely derived from individual case reports and small case series.

Common questions about Spheroid body myopathy